Cargando…
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
BACKGROUND: Antibiotic exposure has been associated with worse outcomes with immune checkpoint inhibitors (ICIs) in cancer patients, likely due to disruption of the gut microbiome. Other commonly prescribed medications, such as proton pump inhibitors (PPIs) and histamine-2-receptor antagonists (H2RA...
Autores principales: | Jun, Tomi, Ozbek, Umut, Dharmapuri, Sirish, Hardy-Abeloos, Camille, Zhu, Huili, Lin, Jung-Yi, Personeni, Nicola, Pressiani, Tiziana, Nishida, Naoshi, Lee, Pei-Chang, Lee, Chieh-Ju, Hildebrand, Hannah, Nimkar, Neil, Paul, Sonal, Fessas, Petros, Naeem, Muntaha, Bettinger, Dominik, Khan, Uqba, Saeed, Anwaar, Huang, Yi-Hsiang, Kudo, Masatoshi, Rimassa, Lorenza, Marron, Thomas U., Pinato, David J., Ang, Celina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107671/ https://www.ncbi.nlm.nih.gov/pubmed/33995594 http://dx.doi.org/10.1177/17588359211010937 |
Ejemplares similares
-
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
por: Fessas, Petros, et al.
Publicado: (2020) -
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
por: Pinato, David J, et al.
Publicado: (2020) -
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
por: Pinato, David J., et al.
Publicado: (2020) -
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
por: Sharma, Rohini, et al.
Publicado: (2022) -
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma
por: Muhammed, Ambreen, et al.
Publicado: (2021)